Sun Pharma Reshuffles Leadership, Kirti Ganorkar Named MD as Dilip Shanghvi Steps Back from Day-to-Day Operations
Sun Pharma names Kirti Ganorkar as MD, effective September 1, 2025 major leadership reshuffle also includes a new CEO for the North America business. Sun Pharma's Leadership Overhaul: Kirti Ganorkar Appointed as Managing Director Date June 13, 2025 Source Reuters Sun Pharmaceutical Industries Ltd NSE SUNPHARMA In a major corporate restructuring, Sun Pharmaceutical Industries Ltd, India's largest pharmaceutical firm by revenue, has appointed Kirti Ganorkar as the new Managing Director, starting September 1, 2025. Founder and current MD Dilip Shanghvi will continue to guide the company as Executive Chairman of the board This decision marks a pivotal transition as the company gears up for its next phase of global expansion and innovation Leadership Changes Key Updates Kirti Ganorkar, Head of India Business since 2019, to take charge as MD for five years pending shareholder approval Dilip Shanghvi, visionary founder, will remain Executive Director and Chairman Richard As...